In vivo imaging of siRNA delivery and silencing in tumors
暂无分享,去创建一个
Anna Moore | Zdravka Medarova | Wellington Pham | A. Moore | C. Farrar | Z. Medarova | V. Petkova | W. Pham | Christian Farrar | Victoria Petkova
[1] Brian Seed,et al. Codon usage limitation in the expression of HIV-1 envelope glycoprotein , 1996, Current Biology.
[2] R. Bernards,et al. Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.
[3] Paula M Jacobs,et al. Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent , 2006, Investigative radiology.
[4] David L. Lewis,et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice , 2002, Nature Genetics.
[5] R Weissleder,et al. Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. , 1998, Microvascular research.
[6] R. Weissleder,et al. Tumor Cell Endocytosis Imaging Facilitates Delineation of the Glioma–Brain Interface , 1997, Experimental Neurology.
[7] Matthias John,et al. RNAi-mediated gene silencing in non-human primates , 2006, Nature.
[8] T. Ochiya,et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Gambhir,et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.
[10] T. Rana,et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.
[11] Anil K Sood,et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. , 2005, Cancer research.
[12] J. Lieberman,et al. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] Judy Lieberman,et al. RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.
[14] S. Barik,et al. Inhibition of respiratory viruses by nasally administered siRNA , 2005, Nature Medicine.
[15] Jun Fang,et al. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. , 2003, International immunopharmacology.
[16] P. Opolon,et al. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. , 2002, Biochemical and biophysical research communications.
[17] S. Akira,et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.
[18] Anna Moore,et al. In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe , 2004, Cancer Research.
[19] F. Natt,et al. siRNA relieves chronic neuropathic pain. , 2004, Nucleic acids research.
[20] Anton P. McCaffrey,et al. In vivo activity of nuclease-resistant siRNAs. , 2004, RNA.
[21] I. Verma,et al. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] Thomas Tuschl,et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. , 2003, Antisense & nucleic acid drug development.
[23] A. Judge,et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA , 2005, Nature Biotechnology.
[24] N. Zaffaroni,et al. Survivin as a target for new anticancer interventions , 2005, Journal of cellular and molecular medicine.
[25] T. Irimura,et al. Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer , 2004, Clinical Cancer Research.
[26] R Weissleder,et al. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.
[27] H. Paulson,et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia , 2004, Nature Medicine.
[28] J. Behr,et al. Lipid‐mediated siRNA delivery down‐regulates exogenous gene expression in the mouse brain at picomolar levels , 2005, The journal of gene medicine.
[29] A. Aigner,et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.
[30] Judy Lieberman,et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.
[31] Matthias John,et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.
[32] Keith Bowman,et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.
[33] Inder M Verma,et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] Mark E. Davis,et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. , 2005, Cancer research.